- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06879522
Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors (BCS_MAX)
Feasibility and Early Efficacy of the Maximizing Energy Intervention for Decreasing Fatigue Impact in Breast Cancer Survivors
This study is testing a program called Maximizing Energy to see if it can help women who have finished breast cancer treatment manage their fatigue. The study has two main goals:
- Check if the program can be successfully delivered - Researchers will see if women are willing to join and stay in the study, if they follow the program, and if they find it helpful.
- See if the program works - Researchers will compare Maximizing Energy to a general health education program to see which one helps reduce cancer-related fatigue better.
Participant will:
- Take tests to see if they qualify and to measure their fatigue.
- Be randomized to receive Maximizing Energy or Health Education Interventions for 6 sessions over the internet
- After the sessions and again one month later, repeat some tests to see if their fatigue has improved.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15219
- University of Pittsburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- adult (18 years and older) pre and post-menopausal female at birth diagnosed with Stages I-IIIa breast cancer,
- completed primary treatment for breast cancer (surgery, chemotherapy, radiation) at least 6 months prior to ensure that fatigue is stable and chronic, - moderate to severe fatigue based on score ≥ 4 on the 7-point Fatigue Severity Scale,
- able to speak and understand English
- has a mobile device that runs on the Apple or Android platform
Exclusion Criteria:
- major depressive disorder, mania, hypomania, psychosis, or substance abuse in the past 3 months and
- disability due to diagnoses other than breast cancer.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Health Education
|
To control for the effects of interactions with an interventionist, participants in the attention control group will receive the Health Education intervention.
The interventionists will review a workbook covering fatigue, energy conservation, healthy eating, exercise, and relaxation.
Like the MAX intervention, Health Education will be delivered virtually in weekly 30-minute one-on-one sessions for six weeks.
The interventionist provides education on breast cancer-related fatigue, diet, safe physical activities, and energy conservation strategies tailored to individual needs.
A workbook will support learning.
|
|
Experimental: Maximizing Energy
|
A licensed occupational therapist will deliver the intervention.
The Maximizing Energy program combines problem-solving therapy (PST) and energy conservation education.
Participants will participate in 6 virtual once/week sessions for 30 minutes.
The introductory session, they will track their fatigue and identify three key fatigue-related problems.
In session 2, they will prioritize one problem and practice problem-solving steps.
They then implement an action plan and review progress in the next session.
If the solution is ineffective, the therapist helps modify it or create a new one.
If successful, the participant moves to the next problem.
A MAX workbook supports learning, covering intervention details, fatigue education, energy conservation strategies, and problem-solving worksheets.
The goal is to help participants apply these strategies to improve daily life and return to work.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention in the study
Time Frame: Baseline to Week 11 (4 weeks post-intervention)
|
The proportion of participants who remain in the study until its completion relative to those initially enrolled. The retention rate will be calculated separately for the Maximizing Energy and Control Groups using the following formula: (number of participants who completed the study/number of participants initially enrolled)X 100 |
Baseline to Week 11 (4 weeks post-intervention)
|
|
Participant Adherence to treatment: Receipt
Time Frame: Week 7 (post-6-week intervention)
|
The investigators will collect data on the number of intervention sessions attended by participants
|
Week 7 (post-6-week intervention)
|
|
Participant Adherence to treatment: Receipt
Time Frame: Week 7 (post-6-week intervention)
|
Interventionists will rate participant's active engagement in the interventions on the Pittsburgh Participant Rating Scale.
Each session will be scored 1 (no engagement, refusal) to 6 (excellent engagement) by the interventionist conducting the sessions.
|
Week 7 (post-6-week intervention)
|
|
Participant Adherence to treatment: Enactment
Time Frame: Week 7(post-6-week intervention)
|
The investigators will collect interventionist rating of whether participant completed action plan from previous session (3-point scale; 0 = not completed, 2 = plan completed) for the MAX Intervention group only.
|
Week 7(post-6-week intervention)
|
|
Participant Satisfaction with Intervention
Time Frame: Week 7(post-6-week intervention)
|
Client satisfaction is measured using the Client Satisfaction Questionnaire.
The Clients Satisfaction Questionnaire is an 8-item assessment of satisfaction with the intervention program, rated on a 4-point scale that ranges from 1 to 4 in each item.
Higher scores indicate greater satisfaction with the intervention.
|
Week 7(post-6-week intervention)
|
|
Intervention Fidelity
Time Frame: Week 7(post-6-week intervention)
|
All intervention sessions will be video recorded and a random 20 percent will be rated by independent evaluators trained by the principal investigator.
Intervention fidelity for both groups will be assessed using the PST Provider Checklist.
The a priori criterion for adequate fidelity was that equal or greater than 80 percent of intervention sessions are rated with equal or greater than 80 percent of adequate fidelity for the MAX Intervention group while less than 20 percent of intervention sessions are rated with equal or lesser than 20 percent of adequate fidelity for the Health Education group.
|
Week 7(post-6-week intervention)
|
|
Changes in fatigue
Time Frame: Baseline to Week 11 (4 weeks post-intervention)
|
The PROMIS® Item Bank v1.0 - Fatigue - Short Form 13a (FACIT-Fatigue) is a 13-item questionnaire designed to assess fatigue levels and their impact on daily activities and quality of life.
Each item is scored on a 5-point Likert scale (1 = not at all to 5 = very much), with a total score ranging from 13 to 65.
Higher scores indicate greater fatigue, while lower scores suggest less fatigue and better energy levels.
|
Baseline to Week 11 (4 weeks post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in resilience
Time Frame: Baseline to Week 11 (4 weeks post-intervention)
|
The Connor-Davidson Resilience Scale (CD-RISC) is a tool designed to measure an individual's resilience, or ability to adapt to stress and adversity.
It consists of 25 items, each rated on a 5-point Likert scale (0 = not true at all to 4 = true nearly all the time), with total scores ranging from 0 to 100.
Higher scores indicate greater resilience, reflecting stronger coping skills and adaptability in challenging situations.
|
Baseline to Week 11 (4 weeks post-intervention)
|
|
Changes in impact of fatigue in daily life
Time Frame: Baseline to Week 11 (4 weeks post-intervention)
|
The Modified Fatigue Impact Scale (MFIS) is a 21-item questionnaire that assesses the impact of fatigue on physical, cognitive, and psychosocial functioning.
Each item is rated on a 5-point Likert scale (0 = never to 4 = almost always), with a total score ranging from 0 to 84.
Higher scores indicate a greater negative impact of fatigue on daily life, while lower scores suggest minimal interference with functioning.
|
Baseline to Week 11 (4 weeks post-intervention)
|
|
Changes in fatigue severity
Time Frame: Baseline to Week 11 (4 weeks post-intervention)
|
The Fatigue Severity Scale (FSS) is a 9-item questionnaire designed to assess the impact of fatigue on daily life and functioning.
Each item is rated on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree), with total scores ranging from 9 to 63.
Higher scores indicate greater fatigue severity and its interference with daily activities, while lower scores suggest minimal fatigue impact.
|
Baseline to Week 11 (4 weeks post-intervention)
|
|
Change in physical activity: Step Count
Time Frame: Baseline to Week 11 (4 weeks post-intervention)
|
The investigators will collect data on physical activity as a surrogate measure of increase in energy.
The ActiGraph wGT3X-BT® is a validated accelerometer used to measure physical activity outcomes, including step count.
The ActiGraph wGT3X-BT will be worn on the wrist for 5 days to yield three 24 hour data for a mean number of steps taken daily.
|
Baseline to Week 11 (4 weeks post-intervention)
|
|
Change in Physical Activity: Energy Expenditure
Time Frame: Baseline to Week 11 (4 weeks post-intervention)
|
The investigators will collect data on physical activity as a surrogate measure of increase in energy.
The ActiGraph wGT3X-BT® is a validated accelerometer used to measure physical activity outcomes, including energy expenditure.
The ActiGraph wGT3X-BT will be worn on the wrist for 5 days to yield three 24 hour data for a mean energy expenditure daily.
|
Baseline to Week 11 (4 weeks post-intervention)
|
|
Change in physical activity: Intensity of Activity
Time Frame: Baseline to Week 11 (4 weeks post-intervention)
|
The investigators will collect data on physical activity as a surrogate measure of increase in energy.
The ActiGraph wGT3X-BT® is a validated accelerometer used to measure physical activity outcomes, including percentage of time spent in sedentary, light, moderate, and vigorous physical activity.
The ActiGraph wGT3X-BT will be worn on the wrist for 5 days to yield three 24 hour data for a percentage of time spent in different intensity activity daily.
|
Baseline to Week 11 (4 weeks post-intervention)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Commonly used strategies to manage fatigue
Time Frame: Baseline to 4-weeks after intervention completion
|
The Energy Conservation Strategies Survey assesses which energy conservation strategies they have used in the past 6 weeks and how effective they perceive these strategies to be in managing their fatigue.
The survey lists 14 strategies.
Strategy effectiveness in managing fatigue is rated on a 10-point scale with 1 indicating not effective and 10 indicating very effective.
|
Baseline to 4-weeks after intervention completion
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ketki Raina, PhD, OTR/L, FAOTA, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY24050068
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer Survivor
-
University of Southern QueenslandNot yet recruitingBreast Cancer SurvivorChina
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Canadian Breast Cancer FoundationCompletedBreast Cancer Survivor | Pediatric Cancer SurvivorCanada
-
Nova Scotia Health AuthorityCanadian Cancer Society (CCS)RecruitingBreast Cancer Survivor | Colorectal Cancer SurvivorsCanada
-
Hadassah Medical OrganizationHebrew University of Jerusalem; Israel Cancer AssociationRecruitingBreast Cancer Survivor | Cancer Related Cognitive ImpairmentIsrael
-
M.D. Anderson Cancer CenterTerminatedPregnant Women | Breast Cancer Survivor | Quality of LifteUnited States
-
Nevsehir Haci Bektas Veli UniversityNot yet recruiting
-
University of OklahomaAmerican Cancer Society, Inc.RecruitingBreast Cancer SurvivorUnited States
-
Memorial Sloan Kettering Cancer CenterAmerican Cancer Society, Inc.Active, not recruiting
-
University of VigoNot yet recruitingBreast Cancer | Breast Cancer Survivor | Breast Cancer Patients | Breast Cancer - FemaleSpain
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedBreast Cancer | Cancer SurvivorUnited States
Clinical Trials on Maximizing Energy Intervention
-
University of PittsburghU.S. Army Medical Research and Development CommandCompletedFatigue | Traumatic Brain Injury
-
Oslo University HospitalCompletedObesity | Dietary Modification | CVDNorway
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedDepression | Pain | Breast Cancer | Fatigue | Sleep Disorders | Anxiety Disorder
-
Istanbul Bilgi UniversityMarmara UniversityCompletedIntermittent Fasting | Metabolic Dysfunction-Associated Fatty Liver DiseaseTurkey
-
University of AarhusUniversity of Copenhagen; University of Southern DenmarkCompletedDiet; Deficiency | Exercise InterventionDenmark
-
University of OtagoHealth Research Council, New ZealandCompleted
-
Charite University, Berlin, GermanyCompleted
-
Hacettepe UniversityNot yet recruitingPolycystic Ovarian Syndrome (PCOS)
-
NYU Langone HealthTerminatedOstheoporosis of the KneeUnited States
-
University Hospital TuebingenDLR German Aerospace CenterEnrolling by invitationBed Rest | Space AnalogueGermany